دورية أكاديمية

Oncogene-mediated alterations in chromatin conformation.

التفاصيل البيبلوغرافية
العنوان: Oncogene-mediated alterations in chromatin conformation.
المؤلفون: Rickman DS; Department of Pathology and Laboratory Medicine, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA., Soong TD, Moss B, Mosquera JM, Dlabal J, Terry S, MacDonald TY, Tripodi J, Bunting K, Najfeld V, Demichelis F, Melnick AM, Elemento O, Rubin MA
المصدر: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2012 Jun 05; Vol. 109 (23), pp. 9083-8. Date of Electronic Publication: 2012 May 21.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
اللغة: English
بيانات الدورية: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Washington, DC : National Academy of Sciences
مواضيع طبية MeSH: Nucleic Acid Conformation*, Chromatin Assembly and Disassembly/*genetics , Trans-Activators/*metabolism, Base Sequence ; Cell Line ; Chromatin Immunoprecipitation ; DNA Primers/genetics ; Flow Cytometry ; High-Throughput Nucleotide Sequencing ; Humans ; In Situ Hybridization, Fluorescence ; Karyotyping ; Molecular Sequence Data ; Reverse Transcriptase Polymerase Chain Reaction ; Transcriptional Regulator ERG
مستخلص: Emerging evidence suggests that chromatin adopts a nonrandom 3D topology and that the organization of genes into structural hubs and domains affects their transcriptional status. How chromatin conformation changes in diseases such as cancer is poorly understood. Moreover, how oncogenic transcription factors, which bind to thousands of sites across the genome, influence gene regulation by globally altering the topology of chromatin requires further investigation. To address these questions, we performed unbiased high-resolution mapping of intra- and interchromosome interactions upon overexpression of ERG, an oncogenic transcription factor frequently overexpressed in prostate cancer as a result of a gene fusion. By integrating data from genome-wide chromosome conformation capture (Hi-C), ERG binding, and gene expression, we demonstrate that oncogenic transcription factor overexpression is associated with global, reproducible, and functionally coherent changes in chromatin organization. The results presented here have broader implications, as genomic alterations in other cancer types frequently give rise to aberrant transcription factor expression, e.g., EWS-FLI1, c-Myc, n-Myc, and PML-RARα.
References: Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2105-10. (PMID: 18245377)
Mol Cell. 2007 Aug 3;27(3):380-92. (PMID: 17679089)
Nature. 2009 Nov 5;462(7269):58-64. (PMID: 19890323)
Neoplasia. 2008 Feb;10(2):177-88. (PMID: 18283340)
J Clin Oncol. 2011 Sep 20;29(27):3659-68. (PMID: 21859993)
PLoS One. 2008 Jul 02;3(7):e2572. (PMID: 18596907)
Mol Cell. 2007 Oct 26;28(2):337-50. (PMID: 17964271)
Nat Genet. 2010 Jan;42(1):53-61. (PMID: 20010836)
Science. 2009 Oct 9;326(5950):289-93. (PMID: 19815776)
BMC Cancer. 2007 Apr 12;7:64. (PMID: 17430594)
Nat Genet. 2007 Jan;39(1):41-51. (PMID: 17173048)
Science. 1996 Jul 26;273(5274):494-7. (PMID: 8662537)
PLoS Biol. 2007 Aug;5(8):e192. (PMID: 17622196)
Cancer Cell. 2011 May 17;19(5):664-78. (PMID: 21575865)
Neoplasia. 2010 Jul;12(7):590-8. (PMID: 20651988)
Nat Protoc. 2007;2(10):2366-82. (PMID: 17947979)
Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6579-84. (PMID: 21464326)
J Exp Med. 2008 Apr 14;205(4):785-98. (PMID: 18347100)
Genet Test. 2000;4(1):9-14. (PMID: 10794355)
Cell. 2008 Jul 11;134(1):85-96. (PMID: 18614013)
Mol Cell Biol. 2010 Nov;30(22):5306-17. (PMID: 20855525)
Cell. 2012 Mar 2;148(5):908-21. (PMID: 22341456)
PLoS Biol. 2008 Dec 2;6(12):2911-27. (PMID: 19053175)
Oncogene. 2000 Dec 18;19(55):6514-23. (PMID: 11175367)
Nat Genet. 2004 Oct;36(10):1065-71. (PMID: 15361872)
Nature. 2011 Feb 10;470(7333):214-20. (PMID: 21307934)
Genes Dev. 2011 Oct 15;25(20):2147-57. (PMID: 22012618)
Nat Struct Mol Biol. 2007 Nov;14(11):1049-55. (PMID: 17984967)
Neoplasia. 2009 Aug;11(8):804-11. (PMID: 19649210)
Blood. 2008 Apr 1;111(7):3498-506. (PMID: 18195090)
Science. 2005 Oct 28;310(5748):644-8. (PMID: 16254181)
Science. 2002 Feb 15;295(5558):1306-11. (PMID: 11847345)
Nat Genet. 2006 Nov;38(11):1341-7. (PMID: 17033624)
Cancer Cell. 2010 May 18;17(5):443-54. (PMID: 20478527)
Neoplasia. 2010 Dec;12(12):1031-40. (PMID: 21170267)
معلومات مُعتمدة: R01 CA104348 United States CA NCI NIH HHS; R01 CA125612 United States CA NCI NIH HHS; R01 CA179100 United States CA NCI NIH HHS; CA125612 United States CA NCI NIH HHS
سلسلة جزيئية: GEO GSE37752
المشرفين على المادة: 0 (DNA Primers)
0 (ERG protein, human)
0 (Trans-Activators)
0 (Transcriptional Regulator ERG)
تواريخ الأحداث: Date Created: 20120523 Date Completed: 20120827 Latest Revision: 20220311
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC3384175
DOI: 10.1073/pnas.1112570109
PMID: 22615383
قاعدة البيانات: MEDLINE
الوصف
تدمد:1091-6490
DOI:10.1073/pnas.1112570109